Implementing early-warning indicators of HIV drug resistance in the Caribbean

Clinical Infectious Diseases

Volumn 54, Issue SUPPL. 4, 2012, Pages

  Jack, Noreen ^a   Ravasi, Giovanni ^b   Schrooten, Ward ^c,d   Sutherland, Donald ^e   Ghidinelli, Massimo ^c   Del Riego, Amalia ^a  

^a PAN AMERICAN HEALTH ORGANIZATION   (Trinidad and Tobago)

^b PAN AMERICAN HEALTH ORGANIZATION   (Brazil)

^c PAN AMERICAN HEALTH ORGANIZATION   (United States)

^d HASSELT UNIVERSITY   (Belgium)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CENTRAL AMERICA; HEALTH CARE PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; PATIENT MONITORING; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

ANTI-RETROVIRAL AGENTS; CARIBBEAN REGION; DELIVERY OF HEALTH CARE; DRUG RESISTANCE, VIRAL; HEALTH STATUS INDICATORS; HIV INFECTIONS; HUMANS; LOST TO FOLLOW-UP; MEDICATION ADHERENCE; PATIENT COMPLIANCE; POPULATION SURVEILLANCE; WORLD HEALTH ORGANIZATION;

EID: 84860373288     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir1044     Document Type: Article

References (9)

1. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2010. Available at: http://www.unaids.org/GlobalReport/default. htm. Accessed 15 July 2011.
2. WHO, UNAIDS, UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2010. Available at: http://whqlibdoc.who.int/publications/2010/9789241500395-eng.pdf.Accessed 15 July 2011.
3. World Health Organization. HIV drug resistance early warning indicators, 2010 update. 2010: 1-45. Available at: http://www.who.int/hiv/topics/ drugresistance/hiv-dr-early-warning-indicators.pdf.Accessed 20May 2011.
4. Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir Ther 2008; 13(Suppl 2):1-13. (Pubitemid 352019085)
5. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach, WHO, 2006 revision. Available at: http://www.who.int/hiv/pub/arv/adult/en/index.html. Accessed 23 May 2011.
6. Caribbean Guidelines for the care and treatment of persons with HIV infection: recommendations for antiretroviral therapy for adults and adolescents with HIV infection. Trinidad and Tobago: CARECPAHO/WHO, 2007.
7. Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: a systematic review of developed and developing nation patient reported barriers and facilitators. PLoS Med 2006; 3:e438.
8. El-Khatib Z, Katzenstein D, Marrone G, et al. Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa. PLoS One 2011; 6:e17518.
9. McMahon JH, Jordan MR, Kelley K, et al. Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis 2011; 52:493-506.